{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:38:37Z","timestamp":1768873117209,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cmi.2024.01.022","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T08:24:46Z","timestamp":1706948686000},"page":"877-882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["How I manage severe bacterial infections in people who inject drugs"],"prefix":"10.1016","volume":"30","author":[{"given":"Andrew J.","family":"Stewardson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua S.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian J.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Y.C.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.01.022_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.annemergmed.2016.10.007","article-title":"Quick SOFA scores predict mortality in adult emergency department patients with and without suspected infection","volume":"69","author":"Singer","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.13.1800124","article-title":"Clonal expansion of community-associated meticillin-resistant Staphylococcus aureus (MRSA) in people who inject drugs (PWID): prevalence, risk factors and molecular epidemiology, Bristol, United Kingdom, 2012 to 2017","volume":"24","author":"Packer","year":"2019","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2024.01.022_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00284-016-1165-y","article-title":"High perineal and overall frequency of Staphylococcus aureus in people who inject drugs, compared to non-injectors","volume":"74","author":"Dahlman","year":"2017","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.cmi.2024.01.022_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.12974","article-title":"Risk of new bloodstream infections and mortality among people who inject drugs with infective endocarditis","volume":"3","author":"Tan","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2024.01.022_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3201\/eid2404.171807","article-title":"Reemergence of intravenous drug use as risk factor for candidemia, Massachusetts, USA","volume":"24","author":"Poowanawittayakom","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/archinte.1982.00340210181041","article-title":"Acute pyrogenic reaction in illicit drug users","volume":"142","author":"Blanck","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib8","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2024.01.022_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2024.01.022_bib10","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2014","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2024.01.022_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011117.pub2","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2024.01.022_bib12","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/dar.13525","article-title":"Acute injection-related infections requiring hospitalisation among people who inject drugs: clinical features, microbiology and management","volume":"41","author":"Langham","year":"2022","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.cmi.2024.01.022_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsat.2016.05.008","article-title":"Evaluating the impact of hospital based drug and alcohol consultation liaison services","volume":"68","author":"Reeve","year":"2016","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.cmi.2024.01.022_bib14","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1093\/ofid\/ofx163.811","article-title":"Implementation of a standardized protocol for hospitalized patients who inject drugs and require long-term antibiotics reduces length of stay without increasing 30-day readmissions","volume":"4","author":"Rolfe","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac688","article-title":"Integrated infectious disease and substance use disorder care for the treatment of injection drug use-associated infections: a prospective cohort study with historical control","volume":"10","author":"Serota","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib16","article-title":"Improving care for individuals with serious infections who inject drugs","volume":"9","author":"Kershaw","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib17","article-title":"Description and outcomes of patients with substance use disorder with serious bacterial infections who had a multi-disciplinary care conference","volume":"9","author":"Conte","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab633","article-title":"Patients with serious injection drug use-related infections who experience patient-directed discharges on oral antibiotics have high rates of antibiotic adherence but require multidisciplinary outpatient support for retention in care","volume":"9","author":"Lewis","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib19","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1161\/CIR.0000000000001090","article-title":"Management of infective endocarditis in people who inject drugs: a scientific statement from the American Heart Association","volume":"146","author":"Baddour","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cmi.2024.01.022_bib20","first-page":"4082","article-title":"Infective endocarditis in people who inject drugs: report from the Italian registry of infective endocarditis","volume":"11","author":"Cecchi","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.athoracsur.2020.03.089","article-title":"The evolving burden of drug use associated infective endocarditis in the United States","volume":"110","author":"Geirsson","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cmi.2024.01.022_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cid\/ciz869","article-title":"Long-term outcomes are poor in intravenous drug users following infective endocarditis, even after surgery","volume":"71","author":"Straw","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/ciy1064","article-title":"Drug use and postoperative mortality following valve surgery for infective endocarditis: a systematic review and meta-analysis","volume":"69","author":"Hall","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","article-title":"Clinical outcomes of infective endocarditis in injection drug users","volume":"73","author":"Rudasill","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cmi.2024.01.022_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jacc.2020.11.062","article-title":"Prospective cohort study of infective endocarditis in people who inject drugs","volume":"77","author":"Pericas","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cmi.2024.01.022_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004049","article-title":"Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: a cohort study in New South Wales, Australia","volume":"19","author":"Brothers","year":"2022","journal-title":"PLOS Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjmed.2021.08.007","article-title":"Patient-directed discharges among persons who use drugs hospitalized with invasive Staphylococcus aureus infections: opportunities for improvement","volume":"135","author":"Appa","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib28","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.2105\/AJPH.2015.302885","article-title":"Leaving the hospital against medical advice among people who use illicit drugs: a systematic review","volume":"105","author":"Ti","year":"2015","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cmi.2024.01.022_bib29","doi-asserted-by":"crossref","first-page":"e2484","DOI":"10.1093\/cid\/ciaa1126","article-title":"Against medical advice discharges in injection and non-injection drug use-associated infective endocarditis: a nationwide cohort study","volume":"73","author":"Kimmel","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/M18-2124","article-title":"Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data","volume":"170","author":"Schranz","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12954-021-00581-6","article-title":"Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study","volume":"18","author":"Compton","year":"2021","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.cmi.2024.01.022_bib32","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1093\/cid\/ciaa365","article-title":"Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections","volume":"71","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/jts.22286","article-title":"Childhood trauma and the inability to access hospital care among people who inject drugs","volume":"31","author":"Randhawa","year":"2018","journal-title":"J\u00a0Trauma Stress"},{"key":"10.1016\/j.cmi.2024.01.022_bib35","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1016\/S2214-109X(23)00058-X","article-title":"Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review","volume":"11","author":"Colledge-Frisby","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2024.01.022_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/add.13214","article-title":"Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals","volume":"111","author":"McNeil","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.cmi.2024.01.022_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/add.14393","article-title":"Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs","volume":"114","author":"Grebely","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.cmi.2024.01.022_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s13063-020-04434-8","article-title":"Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs","volume":"21","author":"Midgard","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2024.01.022_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.socscimed.2014.01.010","article-title":"Hospitals as a \u2018risk environment\u2019: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs","volume":"105","author":"McNeil","year":"2014","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0541","article-title":"Simulated cost-effectiveness and long-term clinical outcomes of addiction care and antibiotic therapy strategies for patients with injection drug use-associated infective endocarditis","volume":"5","author":"Adams","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2024.01.022_bib41","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12879-021-06514-9","article-title":"\u201cOPTIONS-DC\u201d, a feasible discharge planning conference to expand infection treatment options for people with substance use disorder","volume":"21","author":"Sikka","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5694\/mja2.51623","article-title":"Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient-centred multi-disciplinary care","volume":"217","author":"Attwood","year":"2022","journal-title":"Med J Aust"},{"key":"10.1016\/j.cmi.2024.01.022_bib43","first-page":"392","article-title":"A\u00a0proposal for addiction and infectious diseases specialist collaboration to improve care for patients with opioid use disorder and injection drug use-associated infective endocarditis","volume":"16","author":"Cortes-Penfield","year":"2022","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy194","article-title":"Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature","volume":"5","author":"Suzuki","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib45","doi-asserted-by":"crossref","first-page":"S494","DOI":"10.1093\/infdis\/jiaa025","article-title":"Feasibility and safety of outpatient parenteral antimicrobial therapy in conjunction with addiction treatment for people who inject drugs","volume":"222","author":"Price","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10096-018-03461-3","article-title":"Outcomes of patients with a history of injecting drug use and receipt of outpatient antimicrobial therapy","volume":"38","author":"O'Callaghan","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib47","first-page":"e70","article-title":"Rethinking home-based outpatient parenteral antibiotic therapy for persons who inject drugs: an opportunity for change in the time of COVID-19","volume":"16","author":"Jawa","year":"2022","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa151","article-title":"A\u00a0narrative review of early oral stepdown therapy for the treatment of uncomplicated Staphylococcus aureus bacteremia: Yay or nay?","volume":"7","author":"Dagher","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib50","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2024.01.022_bib51","article-title":"Oral antibiotic therapy in people who inject drugs (PWID) with bacteraemia","volume":"150","author":"Martinez","year":"2020","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.cmi.2024.01.022_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict"},{"key":"10.1016\/j.cmi.2024.01.022_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02614-20","article-title":"New perspectives on antimicrobial agents: long-acting lipoglycopeptides","volume":"66","author":"Tran","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.01.022_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz028","article-title":"Dalbavancin as secondary therapy for serious Staphylococcus aureus infections in a vulnerable patient population","volume":"6","author":"Bryson-Cahn","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40360-020-00452-z","article-title":"Oritavancin for the treatment of complicated gram-positive infection in persons who inject drugs","volume":"21","author":"Ahiskali","year":"2020","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.cmi.2024.01.022_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40121-019-0247-0","article-title":"Dalbavancin use in vulnerable patients receiving outpatient parenteral antibiotic therapy for invasive gram-positive infections","volume":"8","author":"Bork","year":"2019","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2024.01.022_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa293","article-title":"Use of a standardized dalbavancin approach to facilitate earlier hospital discharge for vulnerable patients receiving prolonged inpatient antibiotic therapy","volume":"7","author":"Vazquez Deida","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz274","article-title":"Long-acting lipoglycopeptides: \u201cLineless antibiotics\u201d for serious infections in persons who use drugs","volume":"6","author":"Morrisette","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib59","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s13063-022-06370-1","article-title":"Dalbavancin as an option for treatment of S.\u00a0aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial","volume":"23","author":"Turner","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2024.01.022_bib60","article-title":"Frame shift: focusing on harm reduction and shared decision making for people who use drugs hospitalized with infections","author":"Thakarar","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.01.022_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12954-022-00624-6","article-title":"Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage","volume":"19","author":"Hrycko","year":"2022","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.cmi.2024.01.022_bib62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/wound.2020.1243","article-title":"Wounds and skin and soft tissue infections in people who inject drugs and the utility of syringe service programs in their management","volume":"10","author":"Sanchez","year":"2021","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"10.1016\/j.cmi.2024.01.022_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109494","article-title":"The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: a retrospective data linkage study","volume":"236","author":"Colledge-Frisby","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cmi.2024.01.022_bib64","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1716771","article-title":"Decolonization to reduce postdischarge infection risk among MRSA carriers","volume":"380","author":"Huang","year":"2019","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:04:10Z","timestamp":1751371450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1198743X24000466"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.01.022","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How I manage severe bacterial infections in people who inject drugs","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}